One future growth star I’d buy over IQE plc

This small-cap has a much better growth outlook than IQE plc (LON: IQE).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

IQE (LSE: IQE) has been one of the market’s star performers over the past year. Since mid-January 2017, the shares have gained more than 230%, outpacing all of the UK’s major indexes. 

Unfortunately, over the past three months, shares in the company have struggled as investors have become concerned about the group’s lofty valuation. At the time of writing the shares are trading at a forward P/E of 32.8.

Betting on growth 

For a high-growth company like IQE, this multiple is easy to justify. The City is currently expecting it to report earnings per share growth of 28.5% for 2017 implying a PEG ratio of 1.2. A PEG ratio of one or less signifies that the shares offer growth at a reasonable price based on growth and valuation estimates. For 2018, analysts are projecting year-on-year earnings growth of 31.6%. If the firm hits this target, the shares are trading at a 2018 P/E of 29.1 and PEG ratio of 0.7. 

So if IQE hit its growth targets for the next two years, then the shares look appropriately priced. However, a lot could go wrong over the next two or three years and if IQE fails to live up to expectations, then I believe investors could end up nursing heavy losses as the company’s valuation falls back to earth. 

With this being the case, I believe that small-cap Fairfx (LSE: FFX) might be a better buy for growth hunters. 

Inflection point 

Over the past five years, Fairfx has been struggling to build its business to scale. Even though revenue has grown at a rate of approximately 36% per annum since 2011, the firm has struggled to break even. 

City analysts expect this to change in the next two years and are expecting the financial services company to report a net profit of £8.1m for 2018 and earnings per share of 5.4p on revenues of £2.5bn. 

The firm is already well on the way to this target. Today it reported that revenues for 2017 are on track to exceed £1.1bn, up 39% year-on-year and both revenues and profits are expected to be “ahead of market expectations for FY17.

2018 is set to be an even better year for the firm. At the end of December, it was given full membership status with Mastercard, allowing it to “issue Mastercard branded cards, initially across Europe but with other regions to follow.” This will allow the company to create third-party card programmes in-house producing cost savings as well as streamlining its services. 

Cheap growth 

With Mastercard on-side, management will also be able to accelerate the growth of CardOneBanking, which was acquired last year. CardOne offers a simple banking service for customers with no credit checks and no branches. So far, over 80,000 customers have signed up for the service. 

As Fairfx continues to build on its existing business of international currency payments and complements this growth with other financial services, the group should be able to keep expanding, and margins should improve, leading to further profit growth. 

Unlike IQE, you don’t have to pay a premium for this growth. The shares are currently trading at a forward P/E of 14.2, which I believe undervalues Fairfx and its growth potential. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »